Management of cytomegalovirus disease with antiviral drugs

Keyphrases

• Antiviral Drugs 100%
• Cytomegalovirus Disease 100%
• Ganciclovir 60%
• Cytomegalovirus Infection 40%
• Acyclovir 40%
• University of Minnesota 20%
• Foscarnet 20%
• Transplant Recipients 20%
• Maintenance Therapy 20%
• Placebo-controlled Trial 20%
• High Dose 20%
• Cytomegalovirus 20%
• Gastrointestinal Diseases 20%
• Immunocompromised Patients 20%
• Clinical Response 20%
• Neutropenia 20%
• Adverse Events 20%
• Allogeneic Bone Marrow Transplantation 20%
• Renal Allograft Recipient 20%
• Difficult-to-treat 20%
• Cytomegalovirus Pneumonia 20%
• Cytomegalovirus Retinitis 20%
• Oral Acyclovir 20%
• Renal Clearance 20%

Medicine and Dentistry

• Cytomegalovirus Infection 100%
• Antiviral Drug 100%
• Aciclovir 42%
• Ganciclovir 42%
• Cytomegalovirus 28%
• Kidney Allograft 14%
• Drug Megadose 14%
• Gastrointestinal Disease 14%
• Adverse Event 14%
• Bone Marrow Transplantation 14%
• Maintenance Therapy 14%
• Neutropenia 14%
• Immunocompromised Patient 14%
• Cytomegalovirus Retinitis 14%
• Foscarnet 14%
• Renal Clearance 14%
• Placebo 14%
• Oral 14%